Chad Mulvany, FHFMA
About the Author
Chad Mulvany, FHFMA
Latest Work
The yin-yang of Medicaid: Expected federal regulations will increase number of uninsured despite increase in states taking expansion dollars
Despite more states considering taking Medicaid expansion dollars, federal regulatory efforts may drive an acceleration in the number of uninsured.
Rising out-of-pocket cost of having a baby can impact hospital revenue and reputation
The increase in consumer out-of-pocket costs for having a baby can have a negative impact on both a hospital’s financial performance and its perception in the community.
Limited BPCI savings seen with joint replacement bundles
CMS’s new BPCI-A model incorporates patient complexity into the risk-adjustment mechanism, but it remains to be seen if it will solve all issues with the previous model.
Analysis: Aspire Health Founder Brad Smith chosen as new CMMI director
The change in CMMI leadership could mean long-anticipated models are released, and may signal more emphasis on palliative care in future models based on Brad Smith’s background.
Analysis: Advanced analytics company partners with Emory Healthcare
If healthcare providers are going to be successful in lowering the cost of healthcare, they may need to find a partner that can crunch the data to help them understand their cost to deliver care at the case/patient level.
Analysis: FY20 appropriations bills passed – lessons for potential future healthcare legislation
A review of the FY20 appropriations package to fund the federal government and a couple of ideas on lessons that might be applied to future efforts to expand coverage.
Analysis: What are the implications for the healthcare industry with more private equity groups buying up various specialty physician practices?
HFMA’s Chad Mulvany looks at the trend of private equity groups rolling up various specialty physician practices and what it could mean for the healthcare industry.
Analysis: CVS launches oncology program marrying precision medicine with care management
The pairing of precision medicine and care management have the potential to significantly reduce spend and improve patient outcomes.
Analysis: ChenMed moves into new territory
ChenMed’s entrance into new markets will likely have an impact on ambulatory-sensitive ED visits and admissions for underserved Medicare Advantage patients.
Analysis: Timeline for CMS’s mandatory radiation oncology model appears to slip
It’s not surprising CMMI has slowed its pace on finalizing the proposed mandatory radiation oncology payment model given the complexity of the model and stakeholder opposition.